Cargando…
Hairy Cell Leukemia Patients Have a Normal Life Expectancy—A 35-Year Single-Center Experience and Comparison with the General Population
SIMPLE SUMMARY: Classic hairy cell leukemia (HCL) is a rare, chronic B-cell malignancy with long-term remissions after standard treatment with purine analogues introduced in the 1990s. Although nearly all patiently ultimately relapse after up to 20 years from therapy requiring retreatment, overall s...
Autores principales: | Bohn, Jan-Paul, Neururer, Sabrina, Pirklbauer, Markus, Pircher, Andreas, Wolf, Dominik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909617/ https://www.ncbi.nlm.nih.gov/pubmed/35267550 http://dx.doi.org/10.3390/cancers14051242 |
Ejemplares similares
-
The Biology of Classic Hairy Cell Leukemia
por: Bohn, Jan-Paul, et al.
Publicado: (2021) -
Low‐dose vemurafenib in hairy cell leukemia patients with active infection
por: Bohn, Jan‐Paul, et al.
Publicado: (2019) -
Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia‐variant
por: Locher, Maurus, et al.
Publicado: (2020) -
Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine
por: Bohn, Jan-Paul, et al.
Publicado: (2022) -
Genomics of Hairy Cell Leukemia
por: Tiacci, Enrico, et al.
Publicado: (2017)